Quotables
"During my service in the United States Congress, I took the initiative in creating the Internet."
Al Gore ; The basis for the later misquote by US Republicans that Gore had "invented" the Internet. Gore was the leading political champion of the modern-day Internet.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7135195 | Treatment of humans with colloidal silver composition We disclose a colorless composition comprising silver particles and water, wherein said particles comprise an interior of elemental silver and an exterior of ionic silver oxide, wherein the silver particles are present in the water at a level of about 5–40 ppm, an... | 11/14/2006 |
| 7094429 | Process for preparing tannate liquid and semi-solid dosage forms An active ingredient from the group of an antihistamine, a decongestant, an antitussive or anticholinergic is dissolved in a suitable solvent and added to a dispersion of tannic acid in water to form the tannate salt complex of the active ingredient. The active ingr... | 08/22/2006 |
| 7087249 | Treatment of mucosal membranes The invention relates to the use of one or more antimicrobial metals preferably selected from silver, gold, platinum, and palladium but most preferably silver, formed with atomic disorder, and preferably in a nanocrystalline form, for reducing inflammation or infect... | 08/08/2006 |
| 7060730 | Rapidly absorbed liquid compositions The present invention provides a method which provides for a faster absorption of pharmaceutically acceptable amines. The method provides a pharmaceutically acceptable amine in combination with a non-steroidal anti-inflammatory drug in a liquid form. A preferred emb... | 06/13/2006 |
| 6989157 | Dry powders of metal-containing compounds Dry powders of metal-containing compounds are disclosed. Methods of preparing and using the dry powders, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, ... | 01/24/2006 |
| 6939550 | Stabilized antihistamine syrup An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid. ... | 09/06/2005 |
| 6932978 | Double-headed, closed-mouth cough suppressant and cold relief device A double-headed, closed-mouth cough suppressant and cold relief device in which an individual having the symptoms of a cough is able to suppress the cough by inserting the device into an open mouth, and by sucking on one end of the device, is able to release a menth... | 08/23/2005 |
| 6932966 | Topically applied reconstituted ocean water mixture and method of producing and using the mixture A skin treatment mixture for treating pierced skin such as that resulting from a body piercing procedure includes sea salt, lysozyme and reconstituted ocean water. The reconstituted ocean water preferably is the product of reverse osmosis of water. The skin treatmen... | 08/23/2005 |
| 6929800 | Nasal passage cleaning composition A nasal passage cleaning composition according to the invention comprises water and salt as a base, and contains a mucolytic agent such as alum and/or zinc sulphate to shrink the mucosa and allow sinus passage drainage, decreasing pressure in the infected sinus an a... | 08/16/2005 |
| 6869618 | Process for preparing tannate liquid and semi-solid dosage forms An active ingredient from the group of an antihistamine, a decongestant, an antitussive or anticholinergic is dissolved in a suitable solvent and added to a dispersion of tannic acid in water to form the tannate salt complex of the active ingredient. The active ingr... | 03/22/2005 |
| 6866871 | Dry powders of metal-containing compounds Dry powders of metal-containing compounds are disclosed. Methods of preparing and using the dry powders, particularly in the treatment of a subject having a condition, are also disclosed. The metal-containing material can be, for example, an antimicrobial material, ... | 03/15/2005 |
| 6790849 | Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants Methods and pharmaceutical compositions employing (+) cetirizine, (−) cetirizine, or racemic cetirizine, or a pharmaceutically acceptable salt thereof, and a leukotriene inhibitor, or a pharmaceutically acceptable salt thereof, or decongestant for the treatment, m... | 09/14/2004 |
| 6767901 | Ciclesonide contained pharmaceutical composition for application to mucosa The present invention provides a pharmaceutical composition for application to the mucosa to be used in drug therapy comprising a water-insoluble and/or water-low soluble substance, ciclesonide, and an aqueous medium, and having an osmotic pressure of less than 290 ... | 07/27/2004 |
| 6703376 | Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients A method of promoting drainage of mucous secretions in the congested airways of a bedridden/immobilized patient or an intubated/mechanically-ventilated patient is disclosed. The method comprises administering to the airways of the patient a uridine phosph... | 03/09/2004 |
| 6696041 | Treatment of colds, flu like infections and other general nasal based infections with a solution containing iodine and other broad spectrum microbicides and a method for its use The invention relates generally to a method which utilizes iodine as a broad spectrum microbicide wherein the active agent may be applied in nasal passages in the manner of a decongestant type nose spray. The spray is intended particularly for human use. ... | 02/24/2004 |
| 6677381 | Guaifenesin tannate The invention pertains to a novel composition comprising guaifenesin tannate and to a method for preparing guaifenesin tannate by reacting guaifenesin with tannic acid at a temperature above the melting point of guaifenesin. The guaifenesin tannate has ex... | 01/13/2004 |
| 6627229 | Antiviral agent and method of producing the same An antiviral agent of an antiviral ability against various viruses and a method of producing the same are provided. A heat treatment is applied to a calcium-containing substance represented by calcium carbonate-containing substances originating from the a... | 09/30/2003 |
| 6558618 | Anti-infection formulation and delivery method A method of dispersing, in water vapor, an anti-infective therapeutic composition (10) into the air in a room (36), in order to treat or prevent transmission of upper respiratory infections, includes: adding to a reservoir of liquid water in a vaporizer (... | 05/06/2003 |
| 6451352 | Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions The invention concerns the use of iso-osmotic saline solutions in particular obtained from sea water, to obtain a medicine designed for a treatment preventing and limiting the release of chemical mediators responsible for causing inflammatory phenomena in... | 09/17/2002 |
| 6384038 | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants Methods and pharmaceutical compositions employing (+) cetirizine, (-) cetirizine, or racemic cetirizine, or a pharmaceutically acceptable salt thereof, and a leukotriene inhibitor, or a pharmaceutically acceptable salt thereof, or decongestant for the tre... | 05/07/2002 |
| 6365624 | Method and composition for delivering zinc to the nasal membrane A viscous gel for delivering minor effective homeopathic amount of zinc or another metal to the nasal membrane.... | 04/02/2002 |
| 6211246 | Rapidly absorbed liquid compositions The present invention provides a method which provides for a faster absorption of pharmaceutically acceptable amines. The method provides a pharmaceutically acceptable amine in combination with a non-steroidal anti-inflammatory drug in a liquid form. A pr... | 04/03/2001 |
| 6180663 | Therapeutic nasal inhalant A therapeutic nasal inhalant for using bioflavanoids as a topical antioxidant. The therapeutic nasal inhalant includes a method for making a therapeutic nasal inhalant composition for treating nasal mucosa. The method comprises the steps of mixing togethe... | 01/30/2001 |
| 6169118 | Flavor blend for masking unpleasant taste of zinc compounds A synergistic flavoring combination of at least two flavoring oils and lauryl alcohol for use in an orally administered formulation which contains an ionizable zinc compound having an undesirable taste, the flavoring combination is unexpectedly effective ... | 01/02/2001 |
| 6121290 | Use of GABA uptake inhibitors as anti-tussive agents Invention is a method of treating cough in a mammal, including a human, which comprises administering to such mammal an effective amount of an inhibitor of GABA uptake.... | 09/19/2000 |
| 6080783 | Method and composition for delivering zinc to the nasal membrane A viscous gel for delivering minor effective homeopathic amount of zinc or another metal to the nasal membrane.... | 06/27/2000 |
| 6063383 | Pharmaceutical suppository composites for fever and influenza and method of producing the composites Pharmaceutical suppository composites for fever and influenza and method of producing them, therefore, are disclosed herein. More particularly, the composites combine all the advantages of traditional Chinese medicine, western medicine, and physical tempe... | 05/16/2000 |
| 6051585 | Single-dose antihistamine/decongestant formulations for treating rhinitis An oral once-per-day single dosage unit for treating the symptoms of rhinitis expertly formulated with a nasal decongestant and antihistamine. Preferably, the antihistamine is non-sedating.... | 04/18/2000 |
| 5869479 | Treatment of upper airway allergic responses Relief from the symptoms of rhinitis is obtained by treatment with: (a) an antihistaminic effective amount of a histamine H1 receptor antagonist; together with (b) a sufficient amount of a histamine H3 receptor antagonist to provide ... | 02/09/1999 |
| 5843466 | Coolant compositions Coolant compositions, flavorant compositions and ingestible and topical compositions containing at least one coolant compound selected from monomenthyl succinate, alkali metal salts of monomenthyl succinate, alkaline earth metal salts of monomenthyl succi... | 12/01/1998 |
| 5837286 | Taste masking for unplatable formulations This invention provides a taste masking composition composed of clove oil and either supportive flavor components or calcium carbonate. This taste masking composition has been found to be particularly useful to mask unpalatable medicinals in formulations ... | 11/17/1998 |
| 5760085 | Topical aromatic releasing compositions The present invention relates to topical aromatic releasing compositions containing one or more volatile aromatic compounds selected from the group consisting of 3-1-menthoxy propane-1,2-diol, N-substituted-p-menthane-3-carboxamides and acyclic carboxamid... | 06/02/1998 |
| 5730997 | Tastemasked liquid pharmaceutical delivery system A substantially tasteless liquid phramaceutical delivery system containing an active material and a high osmolarity aqueous system comprising (i) water; (ii) about 20% to about 45% by weight sugar derivative; (iii) about 10% to about 15% by weight hydroge... | 03/24/1998 |
| 5725865 | Coolant compositions Coolant compositions, flavorant compositions and ingestible and topical compositions containing at least one coolant compound selected from monomenthyl succinate, alkali metal salts of monomenthyl succinate, alkaline earth metal salts of monomenthyl succi... | 03/10/1998 |
| 5726180 | Stabilized solid pharmaceutical preparation and method of producing the same To stabilize the active ingredients, a caffeine is incorporated into a solid pharmaceutical preparation comprising a dextromethorphan and a phenylpropanolamine. The pharmaceutical preparation may further comprise ibuprofen. The active ingredients may be f... | 03/10/1998 |
| 5622992 | Topical aromatic releasing compositions The present invention relates to topical aromatic releasing compositions containing one or more volatile aromatic compounds selected from the group consisting of 3-1-menthoxy propane-1,2-diol, N-substituted-p-menthane-3-carboxamides and acyclic carboxamid... | 04/22/1997 |
| 5560913 | Pharmaceutical compositions The present invention relates to orally ingestible, pharmaceutical compositions containing at least one pharmaceutical active and a taste masking component.... | 10/01/1996 |
| 5534552 | Clear non-alcoholic sinus and allergy medication A clear, hypoallergenic sinus and allergy medication is orally administered in an aqueous, liquid dosage form. The formulation provides effective sinus and allergy relief without alcohol or dyes which adversely affect many allergy sufferers. Said relief i... | 07/09/1996 |
| 5514665 | Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans Methods for reducing the risk of or preventing infections by bacterial pathogens in vivo. In particular, a method for reducing the risk of P. aeruginosa infection in vivo in compromised hosts such as cystic fibrosis patients. The methods involve the use o... | 05/07/1996 |
| 5512290 | Compositions containing 2-acetyl-1-pyrroline A powder-form composition of 2-acetyl-1-pyrroline incorporated with a support of maltodextrin and/or cyclodextrin. The composition is prepared by hydrolyzing a 2-(1-alkoxyethenyl)-1-pyrroline with an acid to obtain a reaction medium, adding an equimolar a... | 04/30/1996 |
